Thoracoabdominal Asynchrony and Respiratory Distress

Recruiting N/A Interventional Study
Respiratory Insufficiency
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
28 Days – 17
Sex
Any
Study type
Interventional
Purpose
Device Feasibility
Participants needed
20 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The investigators hypothesize that a simple 3-point tracking device that uses motion sensors attached to the abdomen and chest of a child will provide information regarding thoracoabdominal asynchrony (TAA), a major component of respiratory distress, and ultimately help guide a clinician to initiate, escalate, de-escalate, or stop respiratory support interventions. AIMS To determine if the TAA-mo…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. patients 28-days to 17-years of age 2. who have respiratory distress and those who do not have respiratory distress Exclusion Criteria: Hardware, clinical care, or dermal injury that would preclude the application of TAA device
Contacts

Ryan Carroll, MD, MPH

7733328178

rcarroll4@mgh.harvard.edu

CONTACT